| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/02/2004 | EP1375509A1 Use of a sapogenin, or a natural extract containing the same, for the treatment of oligoseborrheic dry skin |
| 01/02/2004 | EP1375465A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof |
| 01/02/2004 | EP1374889A1 Method of inducing angiogenesis by micro-organs |
| 01/02/2004 | EP1374853A1 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374852A1 Cosmetic and/or dermatological Composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374851A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374850A1 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374849A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374836A1 Hair-restoring liquid comprising aqueous dispersion of ultrafine titanium particles and process and apparatus for producing the same |
| 01/02/2004 | EP1374832A1 Cosmetics to promote maturation of cornified envelope and method for treatment |
| 01/02/2004 | EP1374831A1 Comsetics or external preparaiotns for skin |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373485A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
| 01/02/2004 | EP1373475A2 Immunotherapy based on dendritic cells |
| 01/02/2004 | EP1373319A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373298A1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same |
| 01/02/2004 | EP1373271A1 Indole derivatives having an inhibitory effect on protein kinases |
| 01/02/2004 | EP1373270A1 Tricyclic quinoxaline derivatives as a uv filter |
| 01/02/2004 | EP1373266A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 01/02/2004 | EP1373264A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors |
| 01/02/2004 | EP1373258A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 01/02/2004 | EP1373257A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/02/2004 | EP1373256A1 Ccr5 antagonists useful for treating aids |
| 01/02/2004 | EP1373249A1 Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 01/02/2004 | EP1373242A1 Dimeric isoflavones |
| 01/02/2004 | EP1373240A2 Retinoid x receptor modulators |
| 01/02/2004 | EP1373234A2 Urokinase inhibitors |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373231A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors |
| 01/02/2004 | EP1373223A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373217A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 01/02/2004 | EP1373206A1 Aryl oxime-piperazines useful as ccr5 antagonists |
| 01/02/2004 | EP1373205A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 01/02/2004 | EP1373204A2 Heterocyclic compounds |
| 01/02/2004 | EP1373185A2 Hydrophobic polyamine analogs and methods for their use |
| 01/02/2004 | EP1372740A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 01/02/2004 | EP1372730A1 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition |
| 01/02/2004 | EP1372698A2 Use of cytokines of the tgf-beta superfamily for the treatment and diagnosis of skin related disorders |
| 01/02/2004 | EP1372696A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/02/2004 | EP1372695A2 Cell damage inhibitor |
| 01/02/2004 | EP1372693A2 Peptides for the treatment of wound contracture |
| 01/02/2004 | EP1372690A2 93870, a human g-protein coupled receptor and uses therefor |
| 01/02/2004 | EP1372685A1 Use of extracts of the plant litchi chinensis sonn. |
| 01/02/2004 | EP1372683A1 Use of an extract of alpinia officinarum rhizomes |
| 01/02/2004 | EP1372668A2 Method of attenuating reactions to skin irritants |
| 01/02/2004 | EP1372664A1 Use of certain steroids for treatment of blood cell deficiencies |
| 01/02/2004 | EP1372659A1 Substances for use in therapy of diseases that are caused by highly proliferative cells |
| 01/02/2004 | EP1372656A1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 01/02/2004 | EP1372648A2 Tie2 receptor kinase inhibitors for treating angiogenic diseases |
| 01/02/2004 | EP1372647A2 Use of substituted imidazo 1,2-a]-pyridine compounds as medicaments |
| 01/02/2004 | EP1372644A2 Use of substituted imidazo 1,2-a]-pyridine-3-yl-amide and imidazo 1,2-a]-pyridine-3-yl-amine compounds as medicaments |
| 01/02/2004 | EP1372634A2 Fumaric acid amides |
| 01/02/2004 | EP1372625A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors |
| 01/02/2004 | EP1372606A2 In-situ gel formation of pectins |
| 01/02/2004 | EP1372597A1 Metronidazole pledgets |
| 01/02/2004 | EP1372412A2 Composition improving age-related physiological deficits and increasing longevity |
| 01/02/2004 | EP1235830B1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS |
| 01/02/2004 | EP1083874B1 Use of a compound for the preparation of a medicament for treating alopecia or promoting hair growth in an animal |
| 01/02/2004 | EP1036062B1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 01/01/2004 | US20040002525 Obesity; osteoporosis |
| 01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
| 01/01/2004 | US20040002521 Antiinflammatory agents; metalloprotease inhibitor; antiarthritic agents; antiallergens; viricides |
| 01/01/2004 | US20040002519 Mixture of hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, insulin elimination promoter and insulin sensitizer with carrier |
| 01/01/2004 | US20040002514 Blocking leukotrienes; skin disorders |
| 01/01/2004 | US20040002511 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators |
| 01/01/2004 | US20040002501 Modulate signal transduction; antitumor, anticancer agents, vision defects, antidiabetic agents, antiinflammatory agents |
| 01/01/2004 | US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient |
| 01/01/2004 | US20040002481 Novel 4-dedimethylaminotetracycline derivatives |
| 01/01/2004 | US20040002473 Pain modulation; incotinence therapy; central nervous system disorders |
| 01/01/2004 | US20040002449 METH1 and METH2 polynucleotides and polypeptides |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002113 Detection and treatment methods for type I diabetes |
| 01/01/2004 | US20040001897 Skin vitalizing composition for external use anti-aging preparation |
| 01/01/2004 | US20040001792 Decoloring hair and skin using ascorbic acid |
| 12/31/2003 | WO2004001004A2 Membrane associated tumor endothelium markers |
| 12/31/2003 | WO2004000854A1 Sulfur-containing phospholipid derivatives |
| 12/31/2003 | WO2004000846A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 12/31/2003 | WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 12/31/2003 | WO2004000838A1 Peptidic compounds as cysteine protease inhibitors |
| 12/31/2003 | WO2004000836A1 Hydroxy pyranone derivative and preparation method thereof |
| 12/31/2003 | WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/31/2003 | WO2004000807A1 Cannabinoid receptor agonists |
| 12/31/2003 | WO2004000781A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 12/31/2003 | WO2004000369A2 Method of magnetically manipulating a cell with magnetisable particles |
| 12/31/2003 | WO2004000368A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 12/31/2003 | WO2004000360A1 Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis |
| 12/31/2003 | WO2004000339A1 Honey-based skin care preparation |
| 12/31/2003 | WO2004000333A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 12/31/2003 | WO2004000324A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 12/31/2003 | WO2004000322A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 12/31/2003 | WO2004000321A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 12/31/2003 | WO2004000308A1 Method of photodynamic diagnosis for vascular diseases |
| 12/31/2003 | WO2004000305A1 Composition for the treatment of skin diseases and for improving hair growth |